Nigeria was able to successfully control its Ebola outbreak through the following actions:
1) It tracked all confirmed Ebola cases and their contacts, placing many under surveillance and monitoring their health.
2) Those who were infected but recovered were isolated in treatment centers and cared for until they were disease free.
3) Officials provided frequent status updates to the public on the number of cases, deaths, recoveries, and those under monitoring to combat the spread of misinformation.
4) Through meticulous tracking and isolation efforts, Nigeria was ultimately able to contain the outbreak from spreading further within its borders.
The document summarizes the 2014-2016 Ebola outbreak in West Africa, the deadliest in history. It describes the origins and spread of the virus in Guinea, Liberia, and Sierra Leone. It discusses factors that contributed to the rapid spread such as weak healthcare systems, cultural burial practices, and a slow international response. Critics argue the IMF, local governments, and WHO failed to adequately address the crisis in its early stages. Over 28,000 cases and 11,000 deaths were reported before the outbreak was declared over in 2016.
This document provides an updated risk assessment of the ongoing Ebola outbreak in West Africa as of July 31, 2014. It summarizes that the outbreak remains uncontrolled with over 1,300 reported cases across Guinea, Liberia, and Sierra Leone. While the risk to the UK is still considered very low, the increasing case numbers and geographical spread may increase risks to UK citizens involved in humanitarian aid efforts in the affected areas. The UK has a high-level response coordinated across government departments to monitor and respond to any potential imported cases.
- Nine countries in the Americas have confirmed local transmission of the Zika virus, including Brazil where transmission was first detected in 2015.
- Brazil has reported an increase in cases of microcephaly, with over 1,200 cases under investigation. Several countries have also reported neurological disorders potentially linked to Zika virus infection.
- Recommendations include strengthening surveillance for Zika virus, neurological syndromes, and congenital malformations. Pregnant women and newborns should be monitored in areas with Zika virus transmission. Vector control and community communication are also recommended.
The document summarizes an epidemiological update on the Ebola virus disease outbreak in West Africa. As of March 15th, there were 14,415 probable and suspected Ebola cases reported across six affected countries, resulting in 5,177 reported deaths. The countries experiencing widespread and intense transmission were Guinea, Liberia, and Sierra Leone, which accounted for the majority of cases and deaths. A few isolated cases and deaths also occurred in Mali, the United States, Spain, and Nigeria.
The document provides information on the Zika virus, including its history, epidemiology, transmission, signs and symptoms, complications, diagnosis, and current situation. It discusses how the virus was first identified in 1947 in Uganda in monkeys and humans in 1952. It outlines its spread to Africa, Asia, the Pacific islands, and the Americas. It also summarizes Brazil reporting over 500,000 suspected Zika cases and the observed increase in Guillain-Barré syndrome and microcephaly linked to the outbreak.
Zika virus is transmitted by daytime-active Aedes mosquitoes and can cause mild fever and rash in humans. It emerged as a global health concern in 2015 when infection during pregnancy was linked to microcephaly and other birth defects. There is no vaccine or treatment, so prevention focuses on avoiding mosquito bites.
This document provides an overview and summary of the 2014 Ebola outbreak in West Africa:
- The death toll has risen above 600 with cases reported in Guinea, Liberia, and Sierra Leone. The outbreak is described as the worst in history and is out of control.
- Ebola is transmitted through contact with infected body fluids and has a high fatality rate. There is no vaccine and treatment is limited to supportive care.
- The World Health Organization and aid groups are struggling to contain the epidemic due to lack of resources, hostility in some communities, and the virus's wide geographic spread. Foreign companies are advised to avoid non-essential travel to affected areas.
The document summarizes the 2014-2016 Ebola outbreak in West Africa, the deadliest in history. It describes the origins and spread of the virus in Guinea, Liberia, and Sierra Leone. It discusses factors that contributed to the rapid spread such as weak healthcare systems, cultural burial practices, and a slow international response. Critics argue the IMF, local governments, and WHO failed to adequately address the crisis in its early stages. Over 28,000 cases and 11,000 deaths were reported before the outbreak was declared over in 2016.
This document provides an updated risk assessment of the ongoing Ebola outbreak in West Africa as of July 31, 2014. It summarizes that the outbreak remains uncontrolled with over 1,300 reported cases across Guinea, Liberia, and Sierra Leone. While the risk to the UK is still considered very low, the increasing case numbers and geographical spread may increase risks to UK citizens involved in humanitarian aid efforts in the affected areas. The UK has a high-level response coordinated across government departments to monitor and respond to any potential imported cases.
- Nine countries in the Americas have confirmed local transmission of the Zika virus, including Brazil where transmission was first detected in 2015.
- Brazil has reported an increase in cases of microcephaly, with over 1,200 cases under investigation. Several countries have also reported neurological disorders potentially linked to Zika virus infection.
- Recommendations include strengthening surveillance for Zika virus, neurological syndromes, and congenital malformations. Pregnant women and newborns should be monitored in areas with Zika virus transmission. Vector control and community communication are also recommended.
The document summarizes an epidemiological update on the Ebola virus disease outbreak in West Africa. As of March 15th, there were 14,415 probable and suspected Ebola cases reported across six affected countries, resulting in 5,177 reported deaths. The countries experiencing widespread and intense transmission were Guinea, Liberia, and Sierra Leone, which accounted for the majority of cases and deaths. A few isolated cases and deaths also occurred in Mali, the United States, Spain, and Nigeria.
The document provides information on the Zika virus, including its history, epidemiology, transmission, signs and symptoms, complications, diagnosis, and current situation. It discusses how the virus was first identified in 1947 in Uganda in monkeys and humans in 1952. It outlines its spread to Africa, Asia, the Pacific islands, and the Americas. It also summarizes Brazil reporting over 500,000 suspected Zika cases and the observed increase in Guillain-Barré syndrome and microcephaly linked to the outbreak.
Zika virus is transmitted by daytime-active Aedes mosquitoes and can cause mild fever and rash in humans. It emerged as a global health concern in 2015 when infection during pregnancy was linked to microcephaly and other birth defects. There is no vaccine or treatment, so prevention focuses on avoiding mosquito bites.
This document provides an overview and summary of the 2014 Ebola outbreak in West Africa:
- The death toll has risen above 600 with cases reported in Guinea, Liberia, and Sierra Leone. The outbreak is described as the worst in history and is out of control.
- Ebola is transmitted through contact with infected body fluids and has a high fatality rate. There is no vaccine and treatment is limited to supportive care.
- The World Health Organization and aid groups are struggling to contain the epidemic due to lack of resources, hostility in some communities, and the virus's wide geographic spread. Foreign companies are advised to avoid non-essential travel to affected areas.
Zika virus poses risks to communities in Puerto Rico and parts of the US. Community health centers are responding by screening pregnant patients, educating communities on risks and prevention, and distributing prevention kits. The National Association of Community Health Centers can help by providing educational materials, lobbying for vaccine development, and raising awareness among clinicians. Coordinated responses are needed due to the threat of local transmission and travel between high-risk areas.
This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
This document discusses Zika virus and provides information about diagnosis and treatment. It begins with two pre-test questions about advising individuals who may have been exposed to Zika virus. The rest of the document summarizes key details about Zika virus, including its history, transmission, clinical manifestations, diagnosis, evaluation of pregnant women exposed, and treatment approaches. Zika virus is an emerging infectious disease that spreads through mosquito bites and can cause microcephaly in babies born to infected mothers. Diagnosis involves laboratory testing of blood and other samples. Evaluation and monitoring of pregnant women exposed focuses on fetal ultrasound screening. Treatment is generally rest, fluids, and acetaminophen.
This document provides an overview of the Zika virus. It begins with definitions and an introduction to the virus. The history section describes its discovery and spread. Key points include it being first isolated in 1947 in Uganda and recent outbreaks in French Polynesia, Brazil, and other Americas countries. The rest of the document covers epidemiology, clinical features, diagnosis, treatment, prevention, and control of the Zika virus. It provides details on transmission, symptoms, complications like Guillain-Barré syndrome, diagnostic testing, current lack of vaccines or treatment, and recommendations to prevent mosquito bites.
Zika virus is a mosquito-borne virus that causes fever, rash and joint pain. It was first discovered in Uganda in 1947 and has since spread to many other countries. It is transmitted primarily via the bites of infected Aedes mosquitoes. While most cases are mild, infection during pregnancy can cause microcephaly in babies. Currently there is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and protecting against mosquito bites.
This document summarizes the history and spread of the Zika virus. It was first isolated in 1947 in Uganda and has since had outbreaks in Africa, Southeast Asia, the Pacific Islands and most recently the Americas. The virus is transmitted by Aedes mosquitoes and causes mild fever, rash and joint pain in most cases. There is growing evidence linking Zika infection during pregnancy to microcephaly and other birth defects. As of late 2015, Brazil was experiencing a major outbreak with over 1,000 reported cases of microcephaly. There is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and using insect repellent.
The document summarizes information about the Zika virus. It discusses how the World Health Organization declared Zika a public health emergency due to its suspected link to microcephaly. It then provides details about the symptoms of Zika virus, how it is transmitted, diagnosed, prevented, and treated. The document also discusses the WHO and CDC responses to Zika and efforts to develop a vaccine.
The document discusses the Zika virus epidemic, providing background on its history and transmission. It notes that Zika virus was first isolated in Uganda in 1947 and is spread primarily via Aedes mosquito bites. The World Health Organization declared Zika a public health emergency in response to a reported link between Zika infection during pregnancy and microcephaly in infants. Over 4,000 suspected cases of microcephaly in Brazil are believed to be related to Zika, though only 270 have been fully verified so far. The virus is maintained in nature by replicating between mosquito vectors and vertebrate hosts.
Zika Virus Surveillance and Reporting in the CaribbeanUWI_Markcomm
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice and developing a strategic, scientific approach to tackling the Zika virus.
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
Zika virus is transmitted primarily through the bite of infected Aedes mosquitoes and can cause fever, rash, joint pain, and conjunctivitis. While usually mild, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have recently occurred in Brazil, the Americas, and the Pacific. Diagnosis involves virus detection or antibody testing, but results can be complicated by cross-reactivity with other flaviviruses like dengue.
Updated Lecture about Zika virus .
Currently I am working in Arar Central Hospital, Arar city
In Saudi Arabia
Please do not hesitate to contact us if you require any further information.
Alsultany@hotmail.com
Zika virus is transmitted by mosquitoes and causes a mild fever illness in adults. It can be serious for pregnant women as it is linked to microcephaly in babies. The virus was first discovered in monkeys in Uganda in 1947 and in humans in 1952. Outbreaks have occurred in Africa, Asia, the Pacific and Americas. Diagnosis involves testing for viral RNA or IgM antibodies. There is no vaccine or treatment, only symptom management. Pregnant women with possible exposure should be tested and their babies monitored for brain abnormalities. Prevention involves protecting against mosquito bites.
This document discusses Zika virus and provides information for clinicians. It describes the epidemiology of Zika virus, including transmission and outbreaks in the Americas. It outlines the clinical presentation of Zika virus disease and discusses diagnostic testing. It also addresses maternal-fetal transmission of Zika virus and the relationship between Zika virus infection during pregnancy and microcephaly in infants.
The document discusses Brazil's experiences with the Zika virus outbreak in Pernambuco from 2015-2016. It describes how an initial outbreak of rash was later confirmed to be Zika virus in July 2015. Later that year, cases of Guillain-Barré syndrome and microcephaly in newborns increased, associated with Zika infections months prior. Surveillance efforts successfully monitored the outbreak through syndromic and universal case reporting, as well as sentinel laboratory testing of pregnant women and newborns. Challenges remained in differentiating Zika from other co-circulating viruses like dengue and chikungunya.
Ebola is a new and deadly disease in Nigeria that spreads quickly from person to person through direct contact with body fluids like blood, vomit, sweat, or saliva of an infected individual. Symptoms like fever, headache, muscle aches, and stomach pain appear 2 to 21 days after exposure. While there is no vaccine, prevention relies on avoiding contact with bushmeat, practicing good hygiene like handwashing, and isolating infected patients through barrier nursing techniques.
1) The document outlines assignments and lessons for math class. It includes a warm-up with 5 questions, notes on comparing and adding/subtracting decimals, and 8 math problems working with decimals for students to simplify. It assigns a set of odd math problems to be completed for homework the next day and schedules a test for the following week.
Zika virus poses risks to communities in Puerto Rico and parts of the US. Community health centers are responding by screening pregnant patients, educating communities on risks and prevention, and distributing prevention kits. The National Association of Community Health Centers can help by providing educational materials, lobbying for vaccine development, and raising awareness among clinicians. Coordinated responses are needed due to the threat of local transmission and travel between high-risk areas.
This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
This document discusses Zika virus and provides information about diagnosis and treatment. It begins with two pre-test questions about advising individuals who may have been exposed to Zika virus. The rest of the document summarizes key details about Zika virus, including its history, transmission, clinical manifestations, diagnosis, evaluation of pregnant women exposed, and treatment approaches. Zika virus is an emerging infectious disease that spreads through mosquito bites and can cause microcephaly in babies born to infected mothers. Diagnosis involves laboratory testing of blood and other samples. Evaluation and monitoring of pregnant women exposed focuses on fetal ultrasound screening. Treatment is generally rest, fluids, and acetaminophen.
This document provides an overview of the Zika virus. It begins with definitions and an introduction to the virus. The history section describes its discovery and spread. Key points include it being first isolated in 1947 in Uganda and recent outbreaks in French Polynesia, Brazil, and other Americas countries. The rest of the document covers epidemiology, clinical features, diagnosis, treatment, prevention, and control of the Zika virus. It provides details on transmission, symptoms, complications like Guillain-Barré syndrome, diagnostic testing, current lack of vaccines or treatment, and recommendations to prevent mosquito bites.
Zika virus is a mosquito-borne virus that causes fever, rash and joint pain. It was first discovered in Uganda in 1947 and has since spread to many other countries. It is transmitted primarily via the bites of infected Aedes mosquitoes. While most cases are mild, infection during pregnancy can cause microcephaly in babies. Currently there is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and protecting against mosquito bites.
This document summarizes the history and spread of the Zika virus. It was first isolated in 1947 in Uganda and has since had outbreaks in Africa, Southeast Asia, the Pacific Islands and most recently the Americas. The virus is transmitted by Aedes mosquitoes and causes mild fever, rash and joint pain in most cases. There is growing evidence linking Zika infection during pregnancy to microcephaly and other birth defects. As of late 2015, Brazil was experiencing a major outbreak with over 1,000 reported cases of microcephaly. There is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and using insect repellent.
The document summarizes information about the Zika virus. It discusses how the World Health Organization declared Zika a public health emergency due to its suspected link to microcephaly. It then provides details about the symptoms of Zika virus, how it is transmitted, diagnosed, prevented, and treated. The document also discusses the WHO and CDC responses to Zika and efforts to develop a vaccine.
The document discusses the Zika virus epidemic, providing background on its history and transmission. It notes that Zika virus was first isolated in Uganda in 1947 and is spread primarily via Aedes mosquito bites. The World Health Organization declared Zika a public health emergency in response to a reported link between Zika infection during pregnancy and microcephaly in infants. Over 4,000 suspected cases of microcephaly in Brazil are believed to be related to Zika, though only 270 have been fully verified so far. The virus is maintained in nature by replicating between mosquito vectors and vertebrate hosts.
Zika Virus Surveillance and Reporting in the CaribbeanUWI_Markcomm
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice and developing a strategic, scientific approach to tackling the Zika virus.
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
Zika virus is transmitted primarily through the bite of infected Aedes mosquitoes and can cause fever, rash, joint pain, and conjunctivitis. While usually mild, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have recently occurred in Brazil, the Americas, and the Pacific. Diagnosis involves virus detection or antibody testing, but results can be complicated by cross-reactivity with other flaviviruses like dengue.
Updated Lecture about Zika virus .
Currently I am working in Arar Central Hospital, Arar city
In Saudi Arabia
Please do not hesitate to contact us if you require any further information.
Alsultany@hotmail.com
Zika virus is transmitted by mosquitoes and causes a mild fever illness in adults. It can be serious for pregnant women as it is linked to microcephaly in babies. The virus was first discovered in monkeys in Uganda in 1947 and in humans in 1952. Outbreaks have occurred in Africa, Asia, the Pacific and Americas. Diagnosis involves testing for viral RNA or IgM antibodies. There is no vaccine or treatment, only symptom management. Pregnant women with possible exposure should be tested and their babies monitored for brain abnormalities. Prevention involves protecting against mosquito bites.
This document discusses Zika virus and provides information for clinicians. It describes the epidemiology of Zika virus, including transmission and outbreaks in the Americas. It outlines the clinical presentation of Zika virus disease and discusses diagnostic testing. It also addresses maternal-fetal transmission of Zika virus and the relationship between Zika virus infection during pregnancy and microcephaly in infants.
The document discusses Brazil's experiences with the Zika virus outbreak in Pernambuco from 2015-2016. It describes how an initial outbreak of rash was later confirmed to be Zika virus in July 2015. Later that year, cases of Guillain-Barré syndrome and microcephaly in newborns increased, associated with Zika infections months prior. Surveillance efforts successfully monitored the outbreak through syndromic and universal case reporting, as well as sentinel laboratory testing of pregnant women and newborns. Challenges remained in differentiating Zika from other co-circulating viruses like dengue and chikungunya.
Ebola is a new and deadly disease in Nigeria that spreads quickly from person to person through direct contact with body fluids like blood, vomit, sweat, or saliva of an infected individual. Symptoms like fever, headache, muscle aches, and stomach pain appear 2 to 21 days after exposure. While there is no vaccine, prevention relies on avoiding contact with bushmeat, practicing good hygiene like handwashing, and isolating infected patients through barrier nursing techniques.
1) The document outlines assignments and lessons for math class. It includes a warm-up with 5 questions, notes on comparing and adding/subtracting decimals, and 8 math problems working with decimals for students to simplify. It assigns a set of odd math problems to be completed for homework the next day and schedules a test for the following week.
Mosabber Hossain presents his investigative report on corruption in Bangladesh's telecommunications sector. He obtained documents showing that influential ruling party members illegally obtained licenses to operate international gateway companies, misappropriating 1000 crore taka. His story was published just before elections and sparked public debate. Though threatened during his investigation, Hossain persisted and received the South Asian Inquirer Investigative Journalism Award for uncovering this largest corruption case in Bangladesh's telecom history.
El documento describe las características de la Web 2.0, incluyendo el uso de las redes sociales y la inteligencia colectiva. Explica que una Biblioteca 2.0 utiliza estas nuevas tecnologías para traspasar fronteras físicas y aumentar la interacción de los usuarios. Asimismo, una Biblioteca Escolar 2.0 es un centro de recursos interactivo que emplea herramientas web 2.0 para satisfacer las demandas de los usuarios y ayudarles a desarrollar habilidades a través de una bibli
Digital Technologies and the Extractive Sector #gijc15gijn
This document discusses challenges facing journalism covering the extractive sector and proposes some solutions. It notes that while more data and tools are available, internal and external pressures have limited in-depth reporting. Internally, newsrooms lack resources for specialized coverage. Externally, companies and governments withhold data and some limit press freedoms. It recommends that non-profits help make data accessible, enable cross-border collaboration, provide training, and support investigative work to counter these pressures and imbalances of power.
04 diseno estructuras de concreto 211 228Jose Vargas
Este documento presenta los requisitos mínimos para el diseño sísmico de estructuras de concreto reforzado. Se describe que las estructuras deben ser capaces de soportar movimientos sísmicos dentro del rango inelástico sin pérdida crítica de resistencia, a través de detalles que permitan una respuesta no lineal dúctil. Se especifican los cálculos requeridos para las fuerzas cortantes y momentos de diseño en vigas, columnas y uniones, considerando la resistencia probable a flexión, para asegurar una
Abastecimiento de agua y alcantarillado joey diapositivasjrach389
El documento describe los sistemas de abastecimiento de agua y alcantarillado. Explica que el abastecimiento de agua incluye depósitos, válvulas y tuberías para suministrar agua potable a una comunidad desde fuentes como pluviales, superficiales o subterráneas. También describe la red de distribución como el conjunto de tuberías que distribuye el agua a los edificios para satisfacer la demanda máxima horaria.
Este documento presenta un manual para el uso del programa ETABS para el análisis estructural. El autor, Juan Music Tomicic del Departamento de Ingeniería Civil de la Universidad Católica del Norte en Chile, desarrolló este manual y material adicional en un CD para facilitar el aprendizaje de estudiantes en el área de estructuras. El manual explica de manera clara y concisa cómo usar los programas ETABS y SAP, destacando que se requiere dominar previamente la teoría para poder usarlos de manera adecuada.
Integrating GIS and Remote Sensing Technology In Contact Tracing Of Ebola Vir...ANUMBA JOSEPH UCHE
Contact tracing, is an essential step in breaking the chain of disease transmission and ending an outbreak. There is need to explore digital tools and skills which will enhance the collection and management of epidemiologic, clinical, and laboratory information for every case. This data is crucial for developing outbreak counter measures. In the context of ebola virus disease (EVD), developing a Geographical Information System (GIS) and remote sensing platform for contacting tracing and monitoring of cases will aid field workers visualize outbreak spread between people as well as provide automated tools that speed contact tracing and spatial data analysis. With a disease as often fatal as Ebola, quickly identifying and following up with those who may have been exposed is key to saving lives and containing the outbreak .
This paper gives a preliminary non-technical insight on how GIS and remote sensing can be integrated into existing methodologies to mitigate the challenges in contact tracing and monitoring of Ebola virus diseases cases in any given geographical location. Invariably, this can also be used to design appropriate tools for monitoring outbreaks of viral hemorrhagic fevers such as Ebola, Marburg, Rift Valley, Lassa, and Crimean-Congo hemorrhagic fevers.
La publication des résultats de l’essai nord américain « Women’s Health Initiative » (WHI) en juillet 2002 a transformé le paysage du traitement hormonal de la ménopause (THM), remettant en question un rapport bénéfices/risques considéré jusqu’à cette date comme nettement favorable. Les augmentations induites par le THM du risque cardiovasculaire et du risque de cancer du sein, démontrées par cet essai, ont conduit les agences européennes du médicament, dont l’Afssaps, à restreindre les indications du THM. L’objectif de ce travail, demandé et financé par l’Afssaps, était de décrire en France, après juillet 2002, l’évolution du recours au THM chez des femmes récemment ménopausées, en termes de fréquence et de nature des traitements utilisés.
In light of the of the Ebola outbreak in West Africa the Yale-Tulane ESF-8 Planning and Response Program has produced this special report.
Since most of our student are not back yet from summer break I reached out to past alumni and members of Team Rubicon to assist in putting this report together.
The report was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.
Any students, past alumni, or volunteers who would like to work on future slides let me know. Assistance is always welcome.
This document provides an overview of the Ebola virus outbreak in West Africa as of April 18, 2014. It summarizes the situation in Guinea and Liberia, where confirmed Ebola cases have been reported. In Guinea, there have been a total of 197 clinical cases and 122 deaths reported. In Liberia, there have been 27 clinical cases and 13 deaths reported. The response has included contact tracing, case isolation and management, training for health workers, and social mobilization efforts. Challenges include limited health resources, infection control issues, and the need to improve community awareness as the outbreak continues.
This document provides an overview of the Ebola outbreak in West Africa as of early October 2014. It summarizes the situation in each affected country, including Guinea, Liberia, and Sierra Leone. It reports case and death counts by country according to the WHO. It also describes challenges faced in responding to the outbreak such as community resistance, lack of healthcare resources, and the economic impacts. International organizations are providing support to response efforts.
In light of the rise in #Ebola Epidemic in West Africa Yale-Tulane ESF-8 Planning and Response Program has produced this special report. Past alumni, graduate students from Tulane and Yale, and members of Team Rubicon have assisted in putting this report together.
The report was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.For those of you who are deploying and would like us to focus in on a specific topic or issue let us know and we’ll do our best go get the materials or information you need. If any of you would like to volunteer to help put the brief together let me know and we’ll add you to our team.
In light of the rise in Ebola Epidemic in West Africa Yale-Tulane ESF-8 Planning and Response Program has produced this special report.. Past alumni, graduate students from Tulane and Yale, and members of Team Rubicon have assisted in putting this report together.
The report was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested..
The Ebola outbreak in West Africa has killed over 1,000 people and experimental treatments are being considered. While Ebola virus disease has a high fatality rate, the current outbreak's magnitude may be underestimated. Countries have taken extreme precautions like cordoning off infected areas, but health officials say such measures must proceed humanely. No approved vaccine or treatment exists, so controlling transmission through safe burials and protective equipment is critical.
An introduction to the 2014 West Africa Ebola outbreak for educational use, with additional sources for health professionals in need of up-to-date information.
Updated on 7th December, 2014, with additional infographics and WHO data.
Infographics may be requested for professional use on a creative commons/source attribution basis (micrognome.priobe.net). An interactive version will be available for educational use via the Nearpod share site.
The document provides information about the Ebola virus, including its classification, symptoms, transmission, outbreak history, and current 2014 West Africa outbreak. It describes how Ebola was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. As of August 2014, over 4,000 cases and 2,500 deaths have been reported in the ongoing outbreak affecting Guinea, Liberia, Nigeria, and Sierra Leone. Ebola is a severe and often fatal disease that is transmitted through direct contact with bodily fluids of infected humans or animals.
Dr John Bergman discusses the true CAUSE of the most recent PANDEMIC SCARE...EBOLA! Get the real facts and research studies that reveal the truth about this "dreaded disease". Did you know that Ebola was discovered back in 1976? Why are we JUST NOW hearing about the risk to Americans? Learn 5 simple steps already proven to eliminate Ebola in Africa.
The document discusses the 2014 Ebola outbreak in West Africa. It notes that on August 8, 2014, the WHO declared the outbreak a Public Health Emergency of International Concern due to the scale of the outbreak across multiple countries, the severity of infections, and weak health systems in affected countries. The declaration came despite delays by the WHO in labeling it an emergency due to experimental containment techniques being ineffective and authorities hesitating to accept the scale of the outbreak.
In the absence of effective treatment and a human vaccine, raising awareness of the risk factors for Ebola infection and the protective measures individuals can take is the only way to reduce human infection and death.
The document discusses the 2014 Ebola outbreak in West Africa, which has become one of the largest and deadliest Ebola outbreaks in history. As of August 28, 2014, the WHO reported over 3,000 cases and 1,500 deaths across five countries - Guinea, Liberia, Sierra Leone, Nigeria, and the Democratic Republic of Congo. The outbreak is caused by the Zaire species of the Ebola virus, which is closely related to variants found in previous outbreaks in Central Africa. Fruit bats are believed to be the natural reservoir of the virus, which can be transmitted to humans through contact with infected animal hosts like chimpanzees.
The document discusses the 2014 Ebola outbreak in West Africa, which has become one of the largest and deadliest Ebola outbreaks in history. As of August 28, 2014, the WHO reported over 3,000 cases and 1,500 deaths across five countries - Guinea, Liberia, Sierra Leone, Nigeria, and the Democratic Republic of Congo. The outbreak is accelerating, with 40% of total cases occurring in the last 3 weeks. The WHO predicts that without control measures, cases could grow to over 20,000 by the end of the outbreak.
1) The document discusses theories that Western pharmaceutical companies and the US Department of Defense may have played a role in manufacturing and spreading Ebola and other diseases in Africa.
2) It notes that the US began clinical trials of an Ebola vaccine just before the 2014 Ebola outbreak, and that the US has a bioweapons research lab in the town at the epicenter of the outbreak.
3) It argues that vaccine makers are pushing for legal immunity to profit from fast-tracked Ebola vaccines while questioning whether an Ebola vaccine will actually work as intended.
Fighting Against Ebola: Public Health and NepalMMC, IOM, Nepal
Ebola virus disease is a severe and often fatal illness in humans that was first identified in 1976. The current 2014-2016 outbreak in West Africa was the largest in history. While supportive care can improve survival rates, there are currently no licensed vaccines or treatments for Ebola. Approximately 3,000-5,000 Nepalese citizens work in the affected regions of West Africa, placing Nepal at risk of an outbreak. However, Nepal is ill-prepared to handle Ebola cases, as its airports lack proper screening and designated treatment hospitals lack necessary resources and isolation facilities. Some experts argue that market incentives have led to a lack of Ebola research by pharmaceutical companies, as the disease primarily affects poor regions of Africa
Nigeria was able to defeat the Ebola virus through a combination of proactive measures, including issuing early warnings, establishing emergency response centers, conducting extensive public education campaigns, and effectively tracking and quarantining individuals exposed to the virus. The first case was introduced by a traveler from Liberia, and Nigeria ultimately saw 19 total cases and 7 deaths before being declared Ebola-free within 3 months. Key factors in Nigeria's successful response included national unity in fighting the disease, stringent preventive measures adopted by the public, and the country's isolated treatment method for each Ebola symptom.
West Africa Ebola Outbreak 1
West Africa Ebola Outbreak
Joseph Toole
Principles of Epidemiology PHE 5015 S01
12 Jun 2016
Introduction
Around two years ago, there was worldwide uproar concerning Ebola. The outbreak had occurred in West Africa with individuals nations’ health departments stretched to the limit while trying to cope with the situation. Well wishing nations had to volunteer in terms of health practitioners and funds among other ways in order to assist the nations. Ebola is an infectious disease that is deadly discovered in Zaire in 1976. It is caused by Ebola virus which can be spread via contact with an infected person. Its spread it’s fast since contact with an infected person’s blood or body fluids. This paper will cover an overview of outbreak in 2014 in West Africa, observations, recommendations and conclusion.
Overview, Investigative methodology and rationale for the topic
The first outbreak of the epidemic was discovered in early 2014. It was reported in countries of West Africa namely: Sierra Lone, Guinea and Liberia. The three countries were the huge victims of the epidemic. Most of the victims of the outbreak died with a few survivors (CDC, 2016 n.d. - a). The reported symptoms among the victims were fatigue, fever, severe headaches, diarrhea, vomiting, abdominal pain and unexplained bleeding (CDC, 2016 n.d.-b). The symptoms are discovered roughly between 2 -21 days after infection. The methodology employed in order to determine the magnitude the outbreak encompassed different aspects. There was laboratory tests, study design and patients, data analysis and ethical considerations played a vital role. Study was carried out around the suspected victims. Lab tests were done via use of victim’s blood or oral swap. Ethical considerations were employed to determine the response of public health to the outbreak and contain it. Data analysis was vital in order to relate each case to a certain geographical location. Data from center for disease, World health Organization, European center for Disease prevention and control, National Institute of health will play a critical role in this paper since it will back up the facts presented. The rationale behind choosing the topic is to assist in comprehending the methods employed by epidemiologists in order to understand diseases in populations determine what disease is affecting the population and finally employ measures to treat as well as prevent its future occurrence.
Ebola in West Africa
Outbreaks in Africa have been reported as early as 2007. The ailment was previously known as Ebola hemorrhagic fever which is capable of affecting both humans and primates. It has a couple of species which include the Sudan virus, Reston virus, Bundibugyo virus, Tae Forest virus and Ebola virus. Reston is common in the monkey species. Few cases have been reported regarding the outbreak since it was discovered ranging from around 1-400 annually. For instance, in Gulu villag.
The document summarizes information about the 2014-2015 Ebola outbreak in West Africa, including statistics on cases and deaths. It describes how the virus is transmitted and symptoms of the disease. It provides an overview of screening and prevention measures taken in Singapore to control the potential spread of Ebola due to international travel.
This document summarizes a seminar presentation on Ebola virus disease (EVD). It provides an overview of EVD outbreaks, case definitions, epidemiology, clinical presentation, diagnosis, treatment, and control/prevention. Key points include: EVD is caused by infection with Ebola virus and transmitted through contact with infected body fluids; symptoms range from fever and fatigue to vomiting and hemorrhaging; diagnosis involves virus detection through antigen/antibody tests or PCR; treatment is supportive care as no vaccine currently exists; control relies on isolation, contact tracing, and barrier precautions.
This document provides summaries of multiple reports on the Ebola virus outbreak in West Africa between August and September 2014. It discusses encouraging signs in Nigeria and Guinea with slowing transmission, challenges in Liberia requiring non-conventional interventions, the unprecedented number of infected medical staff, and experimental therapies using blood from recovered patients showing interest.
Similar to Nigeria ebola management if a crisis (20)
Lancet thougths on ebola crisis, @xemide, @jiwitmanuel, @fminigeriaXEMIDE
@xemide, @jiwitmanuel, @fminigeria
In summary Lancet is saying more resources to ihr because countries failed to back WHO, with enough money to prevent global pandemic.
US is implementing is independent strategy and should be welcomed in the affected countries.
Este documento contiene una lista de nombres de jefes de familia en la comunidad de Tábara Abajo al noreste, así como recursos hidráulicos, calles, viviendas, una escuela y una clínica en la zona. También menciona la carretera Sánchez y el canal que pasa cerca de la presa.
Este documento presenta los resultados de encuestas aplicadas en Constanza, República Dominicana en agosto de 2005. Se analizan los datos cualitativa y cuantitativamente. Los resultados muestran la epidemiología del VIH en la región, incluyendo nacionalidad y ubicación de casos. También se comparan los resultados de encuestas aplicadas a la junta municipal y embarazadas antes y después de recibir educación. Finalmente, se resumen tres entrevistas realizadas a personal clave de organizaciones de salud locales.
Este documento presenta los resultados de un estudio realizado en la comunidad de Tabara Abajo, Azua sobre el comportamiento actual frente al VIH/SIDA. El estudio utilizó observaciones, entrevistas y encuestas. Los resultados mostraron que los conocimientos sobre el VIH son aceptables pero hace falta mejorar la comunicación sobre el uso del condón y disminuir el estigma. Se recomienda capacitar al personal de salud local y proveer más materiales preventivos en áreas de alto riesgo.
La seguridad alimentaria y la industria turistica.XEMIDE
Este documento discute los retos que plantean las enfermedades transmitidas por alimentos para la industria turística en crecimiento de las Américas. Las enfermedades transmitidas por alimentos son un gran problema de salud pública y la principal causa de muerte a nivel mundial. Para que la industria turística siga creciendo y compitiendo en el mercado global, es fundamental implementar programas efectivos de gestión de riesgos alimentarios y análisis de puntos críticos de control para garantizar la seguridad de los alimentos y
Este documento presenta un resumen de un curso de higiene básica. El curso cubre temas como higiene mental, personal y ambiental; almacenamiento y manipulación de alimentos; agentes patógenos y su clasificación; y responsabilidades del personal. El objetivo es elevar la cultura sanitaria de los empleados de un hotel para prevenir la propagación de enfermedades.
Este documento introduce el sistema de análisis de riesgos HACCP (Hazard Analysis Critical Control Points), el cual consiste en 7 principios para identificar puntos críticos de control en un proceso de producción de alimentos y establecer límites y procedimientos de monitoreo para controlar riesgos. Se provee un ejemplo de aplicación de HACCP a una ensalada de pollo, identificando puntos críticos como la temperatura de cocción y almacenamiento.
El documento presenta un programa de control de brotes dirigido por el Dr. Jiwit Manuel Concepción. El programa incluye secciones sobre pensamiento científico, ciclo de vida, cadena de transmisión, vigilancia epidemiológica y un programa de simulacros. El objetivo es entender estos conceptos clave para prevenir y controlar brotes.
Este documento presenta los puntos claves para el monitoreo y control de procesos durante el recibo, almacenamiento, manejo, preparación y servicio de alimentos. Describe los requisitos para cada etapa incluyendo temperaturas adecuadas, tiempos máximos, y procedimientos para descongelación, cocción, enfriamiento y recalentamiento para prevenir la proliferación bacteriana. También identifica las 10 principales causas de enfermedades transmitidas por alimentos, siendo la inadecuada refrigeración de alimentos cocidos la principal causa.
Este documento establece protocolos para el control y prevención de norovirus. Propone un sistema de vigilancia para detectar casos de gastroenteritis causados por norovirus y establecer niveles de alerta para activar protocolos de actuación. Explica que los norovirus son virus muy contagiosos que causan vómitos y diarrea, y se propagan a través de heces, vómito y superficies contaminadas. Recomienda medidas de higiene personal, limpieza y desinfección para prevenir la propagación.
Conceptos importantes sobre higiene basica intermediaXEMIDE
El documento presenta conceptos clave sobre higiene básica e intermedia. Explica términos como microorganismos, fisión binaria, preservación, PEPS, flujo de trabajo, limpieza sobre la marcha, control de plagas, resistencia, GMP, riesgo potencial, control, higiene, bioseguridad alimentaria, infecciones alimentarias, ciclo fecal oral, fuentes de infección y período de incubación.
This document provides an overview of business continuity planning for various disasters. It discusses hurricanes in depth, including categories based on wind speeds and expected damage levels. It also summarizes details of two major hurricanes, Katrina and Wilma, that caused extensive damage and fatalities. The document outlines elements of a business continuity plan, including contact information, identifying critical operations, and selecting off-site recovery locations.
Este documento resume los resultados de una evaluación rápida de la situación del VIH/SIDA en la comunidad de Constanza, La Vega, República Dominicana. La evaluación encontró que los residentes tienen conocimientos limitados sobre VIH/SIDA y métodos preventivos. Los grupos más vulnerables identificados fueron mujeres, adolescentes, hombres que tienen sexo con hombres y trabajadores migratorios. Se recomienda el diseño de un plan estratégico para prevenir y controlar el VIH/SIDA en la comunidad, mejorar la educación sobre salud sexual y
1. How Nigeria Handled the
Ebola Crisis.
Dr. Jíwit Manuel Concepción Concepción.
Xemide Director.
2. Introduction
• Since the begining of Ebola Break out many information surrounded the web.
• Many of this information we thought it was misguided because was focusing in the last breed of Ebola.
• We presently do not know if it could be an airborne desease or not, or if it has mutated from previous forms.
• What we are certain is that the letal rate is over 90%.
• Have we understimated Ebola in Europe, is it necessary a militar or a joint public health and emergency
systems reponse???
• We have many doubts, i hope following the one certain country that has controlled the disease NIGERIA
could guide correct process on handling this outbreak before it goes pandemic…
4. Confirmed Cases Still 10, 4 Now Dead, No Ebola in
Enugu, all Cases Confined to Lagos
• Nigeria has now recorded ten (10) confirmed cases of Ebola Virus
Disease (EVD). Out of these, four (4) have died and six (6) are
currently under treatment. (It is important to note that the number of
confirmed cases remains ten (10) as at today and not eleven (11) as
earlier announced this morning. We regret the error which arose
from double counting in the process of communicating the additional
death from the operational centre in Lagos to the Federal Ministry of
Health). The fourth death recorded today was a Nigerian nurse who
participated in the initial management of the index case.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-
uncategorised/187-confirmed-cases-still-10-4-now-dead-no-ebola-in-enugu-all-
cases-confined-to-lagos
5. Four Additional Ebola Patients Discharged
Home
• The Minister of Health Prof. Onyebuchi Chukwu has announced that
four additional confirmed cases of Ebola Virus Disease who have been
managed successfully and are now disease free have been discharged
home today. It includes two male medical doctors and one female
nurse. The three participated in the treatment of the index case while
the fourth person was a female patient at the time the index was on
admission. This brings to five the total number of patients diagnosed
with Ebola Virus Disease who have now been discharged from
hospital.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-
uncategorised/188-four-additional-ebola-patients-discharged-home
6. 5th death of Ebola Virus Disease
PRESS STATEMENT 19th August 2014
• The Honourable Minister of Health, Prof. Onyebuchi Chukwu regrets
to announce the death, this evening, of one of the primary contacts
of the index Ebola Virus Disease case, the most senior doctor who
participated in the management of the patient, a female consultant
physician. With this unfortunate development the total number of
Ebola Virus related deaths in Nigeria now stands at five. The other
two patients currently under treatment in the isolation wards are
stable and are being taken care of.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-
uncategorised/189-5th-death-of-ebola-virus-disease
7. STATUS UPDATE: No New Confirmed Case of
Ebola Virus Disease in Nigeria
• The Honourable Minister of Health Prof. Onyebuchi Chukwu wishes to
reiterate that at present, Nigeria has only two confirmed cases of Ebola
Virus Disease.
• This clarification follows media reports of five new cases in Lagos State.
This report should be disregarded.
• The minister reiterates that any doubtful information on the outbreak of
Ebola Virus Disease in Nigeria should be verified from the Office of the
Honourable Minister of Health who has the sole authority to announce
confirmed cases as far as disease epidemics in Nigeria are concerned.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-
uncategorised/190-status-update-no-new-confirmed-case-of-ebola-virus-disease-in-nigeria
8. Status Update on Ebola Virus Disease in
Nigeria as at 22nd August 2014
• Nigeria has now recorded the first two (2) cases of Ebola Virus Disease in
secondary contacts of the index case, the Liberian-American.
• The two patients are spouses of primary contacts of the Liberian-
American. They are among the secondary contacts who have been under
surveillance.
• This now brings to four (4) the total number of Ebola Virus Disease
patients currently under treatment at the isolation ward.
• This also means that the total number of cases of Ebola Virus Disease so
far reported in the country is fourteen (14). The number of deaths still
remains five (5), while the number of those successfully managed and
discharged also stands at five (5).
• http://www.health.gov.ng/index.php/news-media/press-releases/9-
uncategorised/191-status-update-on-ebola-virus-disease-in-nigeria-as-at-22nd-august-
2014
9. Minister of Health releases updated EVD status of
Nigeria, gives details of FG's containment efforts
• FEDERAL REPUBLIC OF NIGERIA STATEMENT OF THE HONOURABLE MINISTER OF
HEALTH, PROFESSOR C.O. ONYEBUCHI CHUKWU AT THE 2ND EMERGENCY
NATIONAL COUNCIL ON HEALTH MEETING ON EBOLA VIRUS DISEASE OUTBREAK
IN NIGERIA AT THE BACELONA HOTEL, WUSE II, ABUJA 1ST SEPTEMBER, 2014
• Protocol.
• I welcome all members of the National Council on Health to our 2nd Emergency
meeting on Ebola Virus Disease (EVD), which although we are making significant
progress in curtailing its spread, still remains a National Health Emergency and an
International Public Health Emergency by the World Health Organisation (WHO).
• http://www.health.gov.ng/index.php/news-media/press-releases/9-
uncategorised/193-minister-of-health-releases-updated-evd-status-of-nigeria-gives-
details-of-fg-s-containment-efforts
10. Updated Summary of EVD Status of Nigeria,
by Minister of Health as at Sept. 1 2014
• Minister of Health Prof. Onyebuchi Chukwu makes correction/clarification in his opening speech at the Emergency National
Council on Health Meeting at the Barcelona Hotel, Abuja, today
•
• · Total number of confirmed EVD cases in Nigeria = 17 ( including the index case).
• · Total number managed in Lagos= 14.
• · Number successfully managed in Lagos and discharged= 7
• · Number of deaths in Lagos = 5
• · Number presently on treatment in isolation in Lagos = 2
• · Number of death in Port Harcourt (did not benefit from standard management) = 1( a doctor who treated a secondary
contact of Sawyer's)
• · Number of patients under treatment in PH = 1
• · Number of patient that was 'treated' in PH (no stand treatment) and fully recovered = 1
• Total number of survivors in Nigeria(as of today) =11;
• · Total number of deaths in Nigeria (as of today) = 6.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-uncategorised/194-updated-summary-of-evd-status-of-nigeria-
by-minister-of-health-as-at-sept-1-2014
11. Status of Ebola Virus Disease in Nigeria Monday,
8th September, 2014
• PRESS BRIEFING BY THE MINISTER OF HEALTH, PROF. C. O. ONYEBUCHI CHUKWU
• STATUS OF EBOLA VIRUS DISEASE IN NIGERIA
• MONDAY, 8TH SEPTEMBER, 2014
•
• It has been 50 days since Ebola Virus Disease was imported into Nigeria through Lagos, and 38 days since it
was introduced into Port Harcourt.
• So far, all the cases that have been confirmed in Nigeria are traceable to the index case, the Liberian-
American, Mr. Patrick Sawyer.
• As of this morning the total number of confirmed cases of EVD in Nigeria is nineteen (19), fifteen (15) in
Lagos, four (4) in Port Harcourt.
• The 19th case is the fiancé of one of the primary contacts of Mr. Sawyer’s who died of the disease. The test
results were equivocal but further tests established the disease. He had only mild symptoms and he has
since recovered from the illness. He was quarantined but because of the equivocal test result he was not
placed on active treatment.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-uncategorised/197-status-of-ebola-virus-disease-in-nigeria-
monday-8th-september-2014
12. Update on status of Ebola Virus Disease in
Nigeria Wednesday, 17th September 2014
• For one week now, there has not been a single case of Ebola Virus Disease in Nigeria. The
total number of confirmed EVD cases recorded in Nigeria remains 19, with 7 deaths. The
South African woman who was taken from the Murtala Muhammed International Airport
in Lagos and quarantined on suspicion of EVD tested negative for EVD and other viral
haemorrhagic fevers and has since been discharged from quarantine and has left the
country. Also, a suspected case reported by NLNG tested negative for EVD.
• A number of contacts are still under surveillance in Nigeria, 4 in Lagos State and 344 in
Rivers State. So far, 347 contacts have been discharged from surveillance in Lagos State
while 182 contacts have been discharged from surveillance in Rivers State.
• http://www.health.gov.ng/index.php/news-media/press-releases/9-uncategorised/198-
update-on-status-of-ebola-virus-disease-in-nigeria-wednesday-17th-september-2014
13. Preventive public information
• IEC Materials
• Prevention
• What is Ebola Virus Disease?
• How is Ebola Virus Disease spread?
• What is Viral Haemorrhagic Fever (VHF)s?
15. Prevention
HOW CAN THE PUBLIC PREVENT THE SPREAD OF
EBOLA VIRUS DISEASE WITHIN THE COMMUNITY?
• Ebola Virus Disease is an infectious disease affecting humans and
animals such as monkeys, gorillas, Chimpanzees, bats, antelopes, etc.
Ebola virus disease is transmitted to a person when he/she comes in
contact with the blood or secretions of an infected animal or human
(dead or alive).
• Ebola Virus Disease is a virulent killer, there are no specific treatments
or vaccine for Ebola virus disease and it occurs in sporadic outbreak. It
takes between 2 to 21 days after exposure to the virus for someone
to feel sick and show the signs and symptoms of Ebola Virus Disease.
• http://www.health.gov.ng/ebolainfo/index.php/prevention
16. What is Ebola Virus Disease?
• Where is Ebola Virus Disease found?
• Though the natural habitat of the Ebola virus is unknown, Ebola virus is normally found in an animal host that is native to the African continent.
Where do cases of Ebola Virus Disease occur?
• Outbreaks of Ebola VD have been mainly restricted to Africa. Confirmed cases of Ebola VD have been reported in the Democratic Republic of the Congo, Gabon, Sudan, the Ivory
Coast, Uganda and the Republic of the Congo. Ebola VD is usually spread within a health care setting. However, sporadic isolated cases may occur unnoticed.
How is Ebola Virus Disease spread?
• The manner in which the Ebola virus first appears in a human at the start of an outbreak has not been determined. However, Ebola VD could be spread through the following:
• 1. Direct contact with an infected animal or human;
• 2. Direct contact with the blood and or secretions of an infected person especially within families;
• 3. Contact with contaminated medical equipment such as needles;
• 4. Reuse of unsterilized needles in hospital;
• 5. Eating or handling of the carcass of infected animals;
• 6. Inhalation of contaminated air in hospital environment;
• 7. Use of infected non human primate/bats as food source;
• 8. Non implementation of universal precautions.
• http://www.health.gov.ng/ebolainfo/index.php/2-uncategorised/4-a-article
17. How is Ebola Virus Disease spread?
These animals and many more . . . .
The manner in which the Ebola virus first appears in a human at the start of an outbreak has not been
determined. However, Ebola VD could be spread through the following:
1. Direct contact with an infected animal or human;
2. Direct contact with the blood and or secretions of an infected person especially within families;
3. Contact with contaminated medical equipment such as needles;
4. Reuse of unsterilized needles in hospital;
5. Eating or handling of the carcass of infected animals;
6. Inhalation of contaminated air in hospital environment;
7. Use of infected non human primate/bats as food source;
8. Non implementation of universal precautions.
18. What is Viral Haemorrhagic Fever (VHF)s?
• Viral Haemorrhagic Fevers (VHFs) refer to a group of illnesses that are
caused by viruses that cause haemorrhage. These diseases which are
severe and life threatening include Lassa fever, Ebola virus disease,
Dengue haemorrhagic fever, Marburg, Yellow fever among others.
19. Conclussion
• As we said before the most accurate guide to control Ebola right now is the methods Nigeria Health
Department is undertaking.
• I have not read in any other Europe or USA American publication of airborne Ebola, But Nigeria does not rule
out an airborne posibility.
• We believe that a strong country fast response and correct and proper information could lead to proper
handle of the pandemic.
• We are going to keep this as an ongoing story for development of the crisis.
• All the info i gather is from Nigeria Basic Health home page.
• I dont know Prof. Onyebuchi Chukwu but we congratulate you from far for this great response and saving
many human life and your own citizens.